Effects of strontium on the quality of bone apatite crystals: a paired biopsy study in postmenopausal osteoporotic women.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 23108780.
- Also identified by DOI 10.1007/s00198-012-2181-9.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In paired biopsies of osteoporotic women treated with either strontium ranelate or a placebo for 36 months, characteristics of bone apatite crystals were not influenced by the presence of strontium. The mean rate of substitutions of calcium by strontium ions was 4.5 %. The potential effect of strontium (Sr) on bone apatite crystals was investigated in paired biopsies of osteoporotic women treated with either strontium ranelate (SrRan) or a placebo for 36 months. In ten paired biopsies, crystallinity, apparent length and width/thickness of crystals, interplanar distances, and lattice parameters of unit cells were assessed by X-ray diffraction and selected area electron diffraction. All these parameters, reflecting crystal and unit cell characteristics, were not influenced by the presence of Sr and were similar in SrRan and placebo groups after 36 months of treatment. The mean rate of substitutions of calcium by Sr ions was 4.5 %. Overall, the quality of bone apatite crystals was maintained after 36 months of treatment with SrRan.
Medical subject headings
- Apatites
- Bone Density Conservation Agents
- Bone and Bones
- Organometallic Compounds
- Osteoporosis, Postmenopausal
- Thiophenes